Company / Income Tax per Share
Haemonetics Income Tax per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.88
FY2024
5-year range
$0.39 / $0.88
FY2020-FY2024
Trend
+31.8%
vs FY2023
Sector context
#44 of 154
Health Care
What the data says
At $0.88, Haemonetics's income tax per share ranks #111 of 154 in the Health Care sector. Income Tax per Share has increased for 4 consecutive years, from $-0.13 in FY2020 to $0.88 in FY2024.
Based on SEC 10-K filings.
0.88 in FY2024 with a 5-year CAGR of +33.8%.
Increased from $0.51 to $0.88 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +30.7%
- 5-Year CAGR
- +33.8%
- 10-Year CAGR
- -
Sector benchmark
#111 of 154 in Health CareTop 71% of 154This company $0.88 Sector average $1.06
▼
-16.8% below sector average
Key checks
Key Insights
- Haemonetics's income tax per share has grown for 4 consecutive years.
- In FY2024, income tax per share increased 31.8% year-over-year.
- Ranks #44 out of 154 companies in the Health Care sector.
- Lowest income tax per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.88 | +31.8% |
| FY2023 | $0.67 | +32.0% |
| FY2022 | $0.51 | +28.2% |
| FY2021 | $0.39 | +408.6% |
| FY2020 | -$0.13 | -162.3% |
| FY2019 | $0.21 | -42.4% |
| FY2018 | $0.36 | +29.0% |
| FY2017 | $0.28 | +1280.8% |
| FY2016 | -$0.02 | -156.2% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026